HLA-DRB1 and cancer: Some examples include the association of a specific allele with the occurrence of cancer, the association of HLA-DRB1 heterozygosity with better outcomes in viral infections, and the association of HLA class I homozygosity with checkpoint inhibitor inefficacy in cancer therapies [4–7].